GKOS
Glaukos Corporation · Healthcare
Chief Development Officer Tomas Navratil sold $246K of Glaukos Corporation
Sold$246,175
$117.62Price
2,093Shares
−2%Stake
What GKOS did after the filing
- The stock from Wed, Apr 15 open, $121.02
- −12.0%
- S&P 500, same days
- +8.5%
Measured over 30 trading days, to the May 28 close.
Traded Fri, Apr 10. Filed Tue, Apr 14, 4:07 PM ET, after the close. Returns use the Apr 15 open and the May 28 close. Not investment advice.